CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses cardiac toxicity resulting from cancer treatments, which can lead to heart failure. It aims to develop early detection methods for myocardial damage and explore mitochondrial transplantation as a potential therapy for affected patients.
Cardiac toxicity is one of the most frequent serious side effects of cancer therapy, affecting up to 30% of treated patients.
Cancer treatment-induced cardiotoxicity (CTiCT) can result in severe heart failure.
The trade-off between cancer and chronic heart failure is an immense personal burden with physical and psychological consequences.
Current therapies for CTiCT are suboptimal, featuring poor early detection algorithms and nonspecific heart failure treatments.
Based on our recently published…
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
